Market revenue in 2024 | USD 59.3 million |
Market revenue in 2030 | USD 117.4 million |
Growth rate | 12.1% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.36% in 2024. Horizon Databook has segmented the Italy pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The Italian pancreatic cancer treatment market is growing steadily, driven by increasing cases of the disease and advancements in therapeutic options. According to WHO, Italy recorded 15,710 new cases of pancreatic cancer in 2022.
With the disease contributing to a significant portion of cancer-related mortality. The market is heavily reliant on chemotherapy, with gemcitabine-based treatments being widely used in early and advanced stages of the disease.
In addition, combination therapies such as FOLFIRINOX, which provide improved survival benefits for younger, fit patients, are becoming increasingly popular. Pharmaceutical giants such as AstraZeneca, Novartis AG are key players in the Italian market.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Italy pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account